While no approval date has been confirmed, retatrutide could become available as early as 2027 if it successfully completes the remaining regulatory steps
Semaglutide and other GLP-1 drugs can cause side effects like nausea, diarrhoea, dizziness, stomach pain, and constipation
Timestamps: 00:01:09 Introducing the Case 00:03:44 How to Read a Liver Panel: ALT, AST, GGT, Alk Phos, Albumin Explained 00:10:50 What Is GGT and Why Does It Matter Clinically
A glutathione injection delivers a concentrated dose of this antioxidant directly into the muscle, where it is absorbed steadily, giving your body extra support without depending on a digestive system that handles glutathione from pills rather poorly
The findings suggest that both methods can be effective but vary in their absorption rates, bioavailability, and overall impact on health markers